Maravai LifeSciences Holdings, Inc. (MRVI) Cash Flow Statement
Maravai LifeSciences Holdings, Inc. (MRVI) generated -$25.3M of operating cash flow over the twelve months to 2026-06-30, spent $10.6M on capital expenditure and had free cash flow of -$35.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MRVIMaravai LifeSciences Holdings, Inc.Follow MRVI — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.37 | 0.54 | 0.13 | 0.01 | -0.06 | -0.03 | |
| Capital expenditure | 0.01 | 0.02 | 0.07 | 0.03 | 0.01 | -0.01 | |
| Free cash flow | 0.35 | 0.52 | 0.06 | -0.02 | -0.07 | -0.04 | |
| Share repurchases | 0.00 | 0.00 | — | — | — | — | |
| Stock-based compensation | 0.01 | 0.02 | 0.03 | 0.05 | 0.03 | — |
USD billions · SEC XBRL
Maravai LifeSciences Holdings, Inc. — questions
- What is Maravai LifeSciences Holdings, Inc.'s operating cash flow?
- -$25.3M over the twelve months to 2026-06-30.
- How much does Maravai LifeSciences Holdings, Inc. spend on capital expenditure?
- $10.6M over the twelve months to 2026-06-30.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- -$35.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Maravai LifeSciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.